INTRODUCTION
Recombinant human interferon α2b is a cytokine which has antiviral, antiproliferative and immunomodulator activities. IFN-α2b has been used mainly as a drug for treatment of hepatitis of B and C virus infections. E. coli is the most commonly used host for the production of recombinant proteins. High-cell-density culture has been developed as a widely used method for enhancing productivity of desired bioproducts in E. coli. 1 However, high expression levels of recombinant proteins in E. coli often lead to the formation of inclusion bodies. [2] [3] Thus, a protein refolding procedure is usually necessary. [4] [5] A good recovery of the recombinant protein production results from a high yield of solubilizing and refolding of inclusion bodies. In general, inclusion bodies are solubilized by the use of a high concentration of denaturants such as urea or guanidine, along with a reducting agent such as β-mercaptoethanol. 6, 7, 4 Solubilized proteins are then refolded by slow removal of the denaturant in the presence of oxidizing agent. 8, 4 Protein solubilization using high concentration of denaturants leads to the loss of secondary structure and bioactivity due to random coil formation of protein structure and exposure of the hydrophobic surface. 9 It results in low yield of refolding. With new information, protein aggregates inside inclusion bodies have native-like secondary structure. It is assumed that maintenance of this native-like secondary structure by use of mild solubilization buffer will help in improved recovery of bioactive protein in comparison to solubilization under a high concentration of chaotropic agent due to more easy restoration of native active structure. 10 Rudolph and Fischer developed a pulse refolding method which decreased the refolding volumes by stepwise addition of solubilized protein into the refolding buffer.
11 By keeping the protein concentration at low level in each aliquot, the high final refolding yields at high final protein concentrations were then obtained. Another simple and efficient means to prevent aggregation is the addition of aggregation inhibitors. The commonly used additives are L-arginine, urea, glycerol, Triton X-100, polyethylene glycol, and some denaturants at low concentration. 12 In this study, we established a simplified productive process for IFN-α2b production. We applied a new strategy for solubilization and refolding of IFN IBs by using a solubilizing buffer containing a low concentration of urea at high pH and a pulse refolding with buffer containing urea, aggregation inhibitors. Finally, a one-step affinity chromatographic purification was implemented to isolate the bioactive IFN-α2b.
MATERIALS AND METHODS

Bacterial stain
The organism used in this study was E. coli BL21/pBUG-IFN-α2b made by Institute of Medical Genetics, Pyongyang Medical College of Kim Il Sung University.
Preparation of IFN IBs
The cell pellets were suspended in PBS and disrupted by high-presssure homogenization and the inclusion bodies were collected by centrifugation at 8,000g for 40min. After that, the inclusion bodies were washed by washing buffer containing 4mol/L urea, 1mol/L sodium chloride and 0.5% Triton X-100. 
Immobilized metal chelate affinity chromatography
Refolded IFN α2b was purified through immobilized metal Cu 2+ chelate affinity chromatography. 150mmol/L phosphate buffer, pH 7.2 was used as equilibrating buffer and 0.2mol/L glycine-HCl, pH 2.3 containing 0.3mol/L NaCl as eluting buffer.
Bioactivity assay of IFN α2b
Bioactivity assay of IFN α2b was carried out by WISH/VSV system.
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RESULTS
Solubilization of IFN α2b IBs
Influence of urea concentration of solubilization buffer on the solubilization effect of IFN α2b IBs was investigated. Urea concentration of solubilization buffer was set to different values ranging from 1 to 4mol/L and tested for the influence on the solubilization effect of IFN α2b IBs ( Figure 1 ). As shown in Figure 1 , at the urea concentration of 2mol/L, A 280 of solubilized protein was 4.22, solubilization effect (A 280 /A 450 ) was 23.44 and solubilization rate was 89.73%. No significant difference was detected at higher concentrations. Influence of concentration of IFN α2b IBs on the solubilization effect was also investigated. Concentration of IFNα2b IBs to be solubilized was set to different values ranging from 2.5 to 15 mg/L and tested for the influence on the solubilization effect of IFN α2b IBs ( Figure 2 ). When the IFN α2b IBs concentration was below 12.5mg/mL, solubilization effect (A 280 /A 450 ) of IFN α2b IBs was 25.6, solubilization rate was 89.5% and these values decreased at higher IFN α2b IBs concentration. This result shows that the maximum IFN α2b IBs concentration that allows complete solubilization in the buffer containing 2mol/L urea at pH 12.5 is 12.5mg/mL.
Refolding of IFN α2b IBs
We investigated the influence of urea concentration in refolding buffer on the refolding of IFN α2b. Refolding rate of IFN α2b in the solution of concentration of IBs 10mg/ml was tested at different concentrations of urea ranging from 1 to 4mol/L in refolding buffer (50mmol/L Tris-HCl, pH 8.4). The refolding rate at refolding buffer containing 2mol/L urea was 78.81%, the maximal value and it decreased at higher urea concentrations due to the prolonged dialysis ( Figure 3 ). Refolding effect according to dilution method was investigated. Solubilized IFN α2b sample was diluted in two ways, at one step dilution at the speed of 1mL/min and pulse dilution with fixed intervals. As shown in Figure 4 , pulse dilution gave the refolding rate of 78.53%, which was significantly higher than that at one step dilution. Influence of the quantity of IFN α2b in each aliquot added in refolding buffer on the refolding rate of IFN α2b in pulse dilution was also investigated. The quantity of solubilized IFN that had to be added to refolding buffer in each aliquot was set to different values ranging from 0.1 to 1.0mg/mL to determine the optimal quantity of solubilized IFN α2b. When the quantity of solubilized IFN α2b added in refolding buffer in each aliquot was set to 0.25mg/mL, refolding rate was 79.87%, which was significantly higher than those at bigger quantities ( Figure 5 ). Influence of final IFN α2b concentration in refolding buffer on the refolding added in refolding buffer in each aliquot was set to 0.25mg/mL, refolding rate was 79.87%, which was significantly higher than those at bigger quantities. rate of IFN α2b was investigated. IFN α2b concentration in refolding buffer after the final pulse dilution was set to different values ranging from 0.5-1.5mg/mL and tested for the relationship with refolding rate. The IFN α2b concentration below 1.25mg/mL in refolding buffer gave the refolding rate of 79.45%, which was significantly higher than those at higher concentrations ( Figure 6 ). Finally, we investigated the influence of removal method of denaturant and stabilizing agent on the activity recovery of IFN α2b. The simultaneous and sudden removal of denaturant and stabilizing agent may influence on the stability of refolded protein. In order to completely remove 2mol/L urea and others from refolding buffer, one or multi steps dialysis were done through ultrafiltration membrane 5K. At multi steps dialysis, urea and others concentration were decreased step by step. Dialysis buffer was replaced every hour. At one step dialysis, the same dialysis buffer with multi steps dialysis was used. The multi steps dialysis gave the antiviral activity recovery of 98.73%, which was maintained at the initiation level ( Figure 7) . Establishment of IFNα2b purification procedure through immobilized metal Cu 2+ chelate affinity chromatography.
First, we investigated the influence of elution buffer on the recovery of IFNα2b. In order to test the influence of elution buffer on the IFNα2b recovery through immobilized metal Cu 2+ chelate affinity chromatography, different kinds of low pH elution buffers were used which have high ion concentration or not (Table 1, Figure 8) . The elution buffer which has the composition of 0.2mol/L Glycine-HCl, pH 2.3, 0.3mol/L NaCl gave the highest recovery of 83.71%. Like this, we established the IFNα2b purification procedure through one step immobilized metal Cu 2+ chelate affinity chromatography. IFN α2b recovery at every purification step was shown in Table 2 . The final recovery was 52.89% and specific activity was raised to 1.4×10 8 U/mg protein after Cu 2+ affinity chromatography. As shown in the Figure 9 , 12% SDS-PAGE showed single band of purified IFN-α2b at expected MW height, whose purity was 99.8%.
DISCUSSION
High expression levels of recombinant proteins in E. coli often lead to the formation of inclusion bodies and a protein refolding procedure is usually necessary. A good recovery of the recombinant protein production results from a high yield of solubilizing and refolding of inclusion bodies. In general, inclusion bodies are solubilized by the use of a high concentration of denaturants such as urea or guanidine, along with a reducting agent such as β-mercaptoethanol. With new information, protein aggregates inside inclusion bodies have native-like secondary structure. It is assumed that maintenance of this native-like secondary structure by use of mild solubilization buffer containing low concentration of denaturant will help in improved recovery of bioactive protein in comparison to solubilization under a high concentration of chaotropic agent due to more easy restoration of native active structure. We estimated the solubilizing effect of low concentration urea, denaturant, on IFN IBs. As shown in Figure 1 Thermoinducible overexpression vector , pBUG-mIFN-α2b rate was 89.5% and these values decreased at higher IFN IBs concentration. This result shows that the maximum IFN IBs concentration that can be solubilized completely in the solubilization buffer containing 2mol/L urea at pH 12.5 is 12.5mg/mL ( Figure 2 ). Rudolph and Fischer developed a pulse refolding method which decreased the renaturation volumes by stepwise addition of solubilized protein into the refolding buffer. By keeping the protein concentration at low level in each aliquot, the high final refolding yields at high final protein concentrations were obtained. Another simple and efficient means to prevent aggregation is the addition of aggregation inhibitors. The commonly used additives are L-arginine, urea, glycerol, Triton X-100, polyethylene glycol, and some denaturants at low concentration. We estimated the effect of the pulse refolding method and the low concentration urea as aggregation inhibitor on the refolding of IFN IBs. The concentration of 2mol/L urea at the refolding buffer (50mmol/L Tris-HCl, pH 8.4) gave the maximal refolding rate of 78.81%, which decreased at higher urea concentrations due to the prolonged dialysis ( Figure 3 ). The pulse adding of an aliquot of solubilized IFN IBs gave the refolding rate of 78.53%, which was significantly higher than that at one step dilution ( Figure 4 ). When the quantity of solubilized IFN added in refolding buffer in each pulse adding was 0.25mg/mL, the refolding rate was 79.87%, which was significantly higher than those at bigger quantities ( Figure 5 ). IFN concentration in refolding buffer after the final pulse adding was set to different values ranging from 0.5-1.5mg/mL and tested for the relationship with refolding rate. The final IFN concentration below 1.25mg/mL in refolding buffer gave the refolding rate of 79.45%, which was significantly higher than those at higher concentrations ( Figure 6 ). The simultaneous and sudden removal of denaturant and stabilizing agent may influence on the stability of refolded protein. In order to completely remove 2mol/L urea and others from refolding buffer, one or multi steps dialysis were done through ultrafiltration membrane 5K.
The multi steps dialysis gave the antiviral activity recovery of 98.73%, which was maintained at the initiation level ( Figure 7 ).
We purified the refolded IFN through immobilized metal Cu 2+ chelate affinity chromatography. In order to test the influence of elution buffer on the IFN recovery through immobilized metal Cu 2+ chelate affinity chromatography, different kinds of low pH elution buffers were used which have high ion concentration or not. The elution buffer which has the composition of 0.2mol/L Glycine-HCl, pH 2.3, 0.3mol/L NaCl gave the highest recovery of 83.71% (Table 1, Figure 8 ). The final recovery was 52.89% and specific activity was raised to 1.4×10 8 U/mg protein after Cu 2+ affinity chromatography (Table 2 ). 12% SDS-PAGE showed single band of purified IFN-α2b at expected MW height, whose purity was 99.8% ( Figure 9 ). Large-scale production of Recombinant human Interferon α2b in E. coli with a thermoinducible overexpression system was obtained by applying an effective solubilizing and refolding processes of interferon α2b inclusion bodies. 
